Virology News and Research

Latest Virology News and Research

Researchers uncover how HIV causes abnormalities in antibody-producing cells

HIV wreaks much of its damage by targeting the “orchestra conductor” of the immune system, a key class of T cells—CD4+ T cells—whose destructive relationship with HIV has been well-studied by AIDS researchers.

8 Sep 2004

Long-term outcomes for liver transplantation due to hepatitis C

A new study on liver transplants necessitated by the hepatitis C virus (the most common indication for this type of transplant) found that long-term outcomes are similar to patients receiving transplants due to other diseases.

8 Sep 2004

Advances in gene silencing on the agenda

Recent advances in using 'RNA interference' (RNAi) to improve plant, animal and human health will be the major focus of the CSIRO-hosted Horizons in Livestock Sciences Conference on the Gold Coast from 12-15 September.

8 Sep 2004

50 year old frozen smallpox vaccines are nearly 100 percent effective

Diluted doses of a smallpox vaccine, originally manufactured in the 1950s and stored as a frozen preparation, are nearly 100 percent effective, allowing for expansion of the current stockpile if needed, according to an article in the September 8 issue of JAMA.

8 Sep 2004

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac Biotech Ltd. has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with two doses of either SARS vaccine or placebo.

7 Sep 2004

Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction

A new University of Michigan study has found that the Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction in 1995 by preventing the kinds of severe cases that used to send children, teens and adults to the hospital.

7 Sep 2004

New way of killing dangerous bacteria like the ones which cause anthrax and pneumonia

The new bug-smashing technique uses the bacteria’s own natural enemies, tiny viruses called bacteriophages (or phages), which can infect bacterial cells. The phages make thousands of copies of themselves inside infected bacteria, but then need to dissolve the bacteria’s cell wall to get out and infect other bacterial cells.

7 Sep 2004

Research may significant consequences in leading drug researchers to develop new and more effective means to block influenza and other viruses

Combating viruses is often a frustrating business. Find a way to destroy them - and before you know it, they’ve found a way to defend themselves and neutralize the anti-viral treatment.

5 Sep 2004

Widely used antimalarial drug exhibits antiviral activity against the SARS

Virologists from the Katholieke Universiteit Leuven in Belgium report that chloroquine, a widely used antimalarial drug, exhibits antiviral activity against the SARS coronavirus. Chloroquine is an inexpensive and safe drug available worldwide.

5 Sep 2004

Bird flu has jumped species barrier to cats

Now the United Nations health agency is investigating reports that bird flu, which experts say could mutate into a potentially deadly human pandemic under certain conditions, has now jumped the species barrier to infect cats.

4 Sep 2004

Researchers unravel genetic makeup of ticks to tackle disease

Ticks as small as a freckle can transmit a number of illnesses for which there is no vaccine and, in some cases, no cure. These creatures even could become bioterrorism weapons.

4 Sep 2004

Researchers make discoveries on West Nile virus, monkeypox, and yellow fever

Researchers from the University of Texas Medical Branch at Galveston present significant new discoveries on West Nile virus, monkeypox, and yellow fever

4 Sep 2004

Indiana State health officials report West Nile virus detected in blood donation

Indiana State health officials report that routine screening by the American Red Cross detected West Nile virus in blood donated by a LaGrange County resident. The individual developed no symptoms of West Nile infection. The blood was not put into circulation.

2 Sep 2004

First Parkinson’s gene therapy patient well after 1 year suggesting that the therapy is safe and effective

The first ever patient to have undergone gene therapy for Parkinson’s appears to have come through phase I without a hitch, suggesting that the therapy is safe and effective, reports Marina Murphy in Chemistry & Industry.

2 Sep 2004

World needs to commit more resources to treat people infected with HIV

Leaders of the International AIDS Vaccine Initiative (IAVI) have stressed that as the world commits more resources to treat people infected with HIV, it must also intensify efforts to develop a vaccine to prevent new infections and stop the continuing spread of the virus.

2 Sep 2004

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

Regular psychological counseling for breast cancer patients may do more than just lower their stress and anxiety. A new study says the right kind of intervention can also mean healthier diets, reduced smoking, and most surprising of all – a stronger immune system.

2 Sep 2004

Epimmune presents SIV vaccine study data showing control of virus despite the presence of viral mutations

Epimmune today presented preliminary data from its ongoing SIV rhesus macaque vaccine study at the AIDS Vaccine 2004 conference in Lausanne, Switzerland.

31 Aug 2004

Major trends in AIDS research that the different research teams throughout the world are pursuing

The science will be presented during the conference which is taking place in Lausanne until September 1, 2004. The advances in fundamental research, notably through a better understanding of the complex processes of immune defence, HIV and the functioning of vaccines, promote the genesis and development of new vaccine candidates.

30 Aug 2004

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

The interim data, from 205 volunteers in clinical trials in Kenya, Uganda and the United Kingdom, show that DNA.HIVA and MVA.HIVA are generally safe and well tolerated. However, the candidates’ ability to elicit an anti-HIV cell-mediated immune response is poor, using currently accepted measures of immune response.

30 Aug 2004

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

At the opening ceremony of the Lausanne, Switzerland, AIDS VACCINE '04 conference, leaders in the field of AIDS vaccine research called for increased political and financial commitment to facilitate the development of preventive and therapeutic AIDS vaccines as a public health imperative in fighting HIV/AIDS.

30 Aug 2004

Virology News and Research

Latest Virology News and Research

Researchers uncover how HIV causes abnormalities in antibody-producing cells

Long-term outcomes for liver transplantation due to hepatitis C

Advances in gene silencing on the agenda

50 year old frozen smallpox vaccines are nearly 100 percent effective

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Chickenpox (Varicella) vaccine has saved the U.S. hundreds of millions of dollars since its introduction

New way of killing dangerous bacteria like the ones which cause anthrax and pneumonia

Research may significant consequences in leading drug researchers to develop new and more effective means to block influenza and other viruses

Widely used antimalarial drug exhibits antiviral activity against the SARS

Bird flu has jumped species barrier to cats

Researchers unravel genetic makeup of ticks to tackle disease

Researchers make discoveries on West Nile virus, monkeypox, and yellow fever

Indiana State health officials report West Nile virus detected in blood donation

First Parkinson’s gene therapy patient well after 1 year suggesting that the therapy is safe and effective

World needs to commit more resources to treat people infected with HIV

Counseling for breast cancer patients means healthier diets, reduced smoking and stronger immune systems

Epimmune presents SIV vaccine study data showing control of virus despite the presence of viral mutations

Major trends in AIDS research that the different research teams throughout the world are pursuing

Interim data from human clinical trials of two AIDS vaccine candidates, named DNA.HIVA and MVA.HIVA

Call for increased political and financial commitment to the development of preventive and therapeutic AIDS vaccines

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut